Canale d'Agordo, Italy

Marcello Tibolla


Average Co-Inventor Count = 6.1

ph-index = 5

Forward Citations = 78(Granted Patents)


Location History:

  • Milan, IT (1977 - 1979)
  • Canale d'Agordo, IT (1979 - 1981)

Company Filing History:


Years Active: 1977-1981

Loading Chart...
12 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Marcello Tibolla

Introduction

Marcello Tibolla is a notable inventor hailing from Canale d'Agordo, Italy. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds with anti-allergy properties. With a total of 12 patents to his name, Tibolla's work has the potential to impact the treatment of allergic conditions.

Latest Patents

Among his latest patents, Tibolla has developed 3,4-Dihydro-quinazoline derivatives. These compounds, such as 6-carboxy-2-(2'-ethoxy-phenyl)-3,4-dihydro-4-oxo-quinazoline, are disclosed for their anti-allergy properties. They can be utilized in the treatment of various allergic conditions. Additionally, he has patented substituted 2-vinyl-chromones, which exhibit anti-allergy activity. These compounds have an alkyl or alkenyl substituent at the 3-position and a styryl substituent at the 2-position, showcasing their potential in allergy treatment.

Career Highlights

Tibolla has worked with prominent companies in the pharmaceutical industry, including Carlo Erba S.p.A. His experience in these organizations has contributed to his expertise in developing innovative solutions for allergy treatment.

Collaborations

Throughout his career, Marcello Tibolla has collaborated with notable colleagues such as Gianfederico Doria and Francesco Lauria. These partnerships have likely enhanced his research and development efforts in the field.

Conclusion

Marcello Tibolla's contributions to the field of pharmaceuticals, particularly in anti-allergy compounds, highlight his innovative spirit and dedication to improving health outcomes. His patents reflect a commitment to addressing allergic conditions through scientific advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…